Study of Cingal for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide at 39 Weeks Follow up

PHASE3CompletedINTERVENTIONAL
Enrollment

526

Participants

Timeline

Start Date

December 7, 2017

Primary Completion Date

July 30, 2018

Study Completion Date

July 30, 2018

Conditions
Knee Osteoarthritis
Interventions
COMBINATION_PRODUCT

Cingal

Hyaluronic Acid with Triamcinolone Hexacetonide

DEVICE

Monovisc

Hyaluronic Acid

DRUG

Triamcinolone Hexacetonide

Triamcinolone Hexacetonide

Trial Locations (17)

1051

Health Center of Downtown-Lipotvaros, Orthopedic Outpatient Clinic (Belvárosi-Lipótvárosi Egészségügyi Szolgálat Ortopeadia), Budapest

1145

Uzsoki Hospital, Department of Traumatology, Budapest

6000

Jutrix Medical Llc, Budapest

Unknown

Magyar Honvedseg, Egeszseugyi Kozpont, Balesteti Sebeszeti Osztaly, Budapest

DE KK Ortopediai Klinika, Debrecen

Medidea Bt., Kiskunfélegyháza

Kastelypark Klinka, Tata

Zdrowie Osteo-Medic, Bialystok

Szpital Świętego Łukasza S.A., Bielsko-Biala

NZOZ Medi SPATX, Gliwice

Centrum Medyczne 4M Plus, Krakow

Medical University of Lodz, Lodz

Lubelskie Centrum Diagnostyczne, Świdnik

NOVAMED Jackowiak Krajewski Spółka Jawna, Torun

Centrum Medyczne Amed Warszawa Targówek, Warsaw

ETG Network, Warsaw, Warsaw

ETG Network, Warsaw

Sponsors
All Listed Sponsors
lead

Anika Therapeutics, Inc.

INDUSTRY